3v0l: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{STRUCTURE_3v0l|  PDB=3v0l  |  SCENE=  }}
==Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (2GW)==
===Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (2GW)===
<StructureSection load='3v0l' size='340' side='right' caption='[[3v0l]], [[Resolution|resolution]] 1.75&Aring;' scene=''>
{{ABSTRACT_PUBMED_23836908}}
== Structural highlights ==
<table><tr><td colspan='2'>[[3v0l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3V0L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3V0L FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2GW:5-PHENYL-URIDINE-5-ALPHA-D-GALACTOSYL-DIPHOSPHATE'>2GW</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3ioh|3ioh]], [[3ioi|3ioi]], [[3ioj|3ioj]], [[3v0m|3v0m]], [[3v0n|3v0n]], [[3v0o|3v0o]], [[3v0p|3v0p]], [[3v0q|3v0q]]</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">AB0, ABO ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3v0l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3v0l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3v0l RCSB], [http://www.ebi.ac.uk/pdbsum/3v0l PDBsum]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Glycosyltransferases (GTs) are enzymes that are involved, as Nature's ''glycosylation reagents'', in many fundamental biological processes including cell adhesion and blood group biosynthesis. Although of similar importance as other large enzyme families such as protein kinases and proteases, the undisputed potential of GTs for chemical biology and drug discovery has remained largely unrealized to date. This is due, at least in part, to a relative lack of GT inhibitors and tool compounds for structural, mechanistic and cellular studies. In this study, we have used a novel class of GT donor analogues to obtain new structural and enzymological information for a representative blood group GT. These analogues interfere with the folding of an internal loop and the C-terminus which are essential for catalysis. Our experiments have led to the discovery of an entirely new active site folding mode for this enzyme family, which can be targeted in inhibitor development, similar to the DFG motif in protein kinases. Taken together, our results provide new insights into substrate binding, dynamics and utilization in this important enzyme family, which can very likely be harnessed for the rational development of new GT inhibitors and probes.


==Function==
Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase.,Jorgensen R, Pesnot T, Lee HJ, Palcic MM, Wagner GK J Biol Chem. 2013 Jul 8. PMID:23836908<ref>PMID:23836908</ref>
[[http://www.uniprot.org/uniprot/BGAT_HUMAN BGAT_HUMAN]] This protein is the basis of the ABO blood group system. The histo-blood group ABO involves three carbohydrate antigens: A, B, and H. A, B, and AB individuals express a glycosyltransferase activity that converts the H antigen to the A antigen (by addition of UDP-GalNAc) or to the B antigen (by addition of UDP-Gal), whereas O individuals lack such activity.  


==About this Structure==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[3v0l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3V0L OCA].
</div>
 
== References ==
==Reference==
<references/>
<ref group="xtra">PMID:023836908</ref><references group="xtra"/><references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Jorgensen, R.]]
[[Category: Jorgensen, R.]]
Line 25: Line 34:
[[Category: Manganese]]
[[Category: Manganese]]
[[Category: Metal-binding]]
[[Category: Metal-binding]]
[[Category: Rossman fold]]
[[Category: Rossmann fold]]
[[Category: Secreted]]
[[Category: Secreted]]
[[Category: Signal-anchor]]
[[Category: Signal-anchor]]

Revision as of 17:02, 3 November 2014

Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (2GW)Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (2GW)

Structural highlights

3v0l is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:, ,
Gene:AB0, ABO (Homo sapiens)
Resources:FirstGlance, OCA, RCSB, PDBsum

Publication Abstract from PubMed

Glycosyltransferases (GTs) are enzymes that are involved, as Nature's glycosylation reagents, in many fundamental biological processes including cell adhesion and blood group biosynthesis. Although of similar importance as other large enzyme families such as protein kinases and proteases, the undisputed potential of GTs for chemical biology and drug discovery has remained largely unrealized to date. This is due, at least in part, to a relative lack of GT inhibitors and tool compounds for structural, mechanistic and cellular studies. In this study, we have used a novel class of GT donor analogues to obtain new structural and enzymological information for a representative blood group GT. These analogues interfere with the folding of an internal loop and the C-terminus which are essential for catalysis. Our experiments have led to the discovery of an entirely new active site folding mode for this enzyme family, which can be targeted in inhibitor development, similar to the DFG motif in protein kinases. Taken together, our results provide new insights into substrate binding, dynamics and utilization in this important enzyme family, which can very likely be harnessed for the rational development of new GT inhibitors and probes.

Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase.,Jorgensen R, Pesnot T, Lee HJ, Palcic MM, Wagner GK J Biol Chem. 2013 Jul 8. PMID:23836908[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Jorgensen R, Pesnot T, Lee HJ, Palcic MM, Wagner GK. Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase. J Biol Chem. 2013 Jul 8. PMID:23836908 doi:10.1074/jbc.M113.465963

3v0l, resolution 1.75Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA